Plenty of time till August 14, 2017. The company should buy back share if wants to bring back shareholders confidence. Positive P2/P3 Cancer data could change the whole picture in weeks. Imo
Makes sense to ignore this for now. It definitely should have risen way more than it did today (and yesterday) and it speaks, in my view, to unscrupulous dilution but whatever. Makes little sense to me but obviously the company has a strategy. It may be take in a few million now at a depressed PPS and then r/s which is unfortunate but they will feel little sympathy for day traders or at least that is what management will tell themselves.
News 
Market Data 
Discover 
